05/16/2025
7:45 AM | CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Conduit Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/07/2025
4:35 PM | CONDUIT PHARMACEUTICALS INC. (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
Conduit Pharmaceuticals (Issuer)
Sarborg Ltd (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
05/07/2025
4:36 PM | CONDUIT PHARMACEUTICALS INC. (Subject)
CONDUIT PHARMACEUTICALS INC. (Subject)
CONDUIT PHARMACEUTICALS INC. (Subject)
CONDUIT PHARMACEUTICALS INC. (Subject)
Conduit Pharmaceuticals (Subject)
Sarborg Ltd (Filed by)
| Form SCHEDULE 13G | |
05/06/2025
3:30 PM | CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Conduit Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/30/2025
11:15 PM | CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Conduit Pharmaceuticals (Filer)
| Form EFFECT | |
04/25/2025
3:30 PM | CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Conduit Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/22/2025
4:24 PM | CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Conduit Pharmaceuticals (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
04/17/2025
3:05 PM | Charles Faith L. (Reporting)
CONDUIT PHARMACEUTICALS INC. (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
Conduit Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/16/2025
4:14 PM | CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Conduit Pharmaceuticals (Filer)
| Form PRE 14A | |
04/10/2025
5:00 AM | ASTRAZENECA PLC (Filed by)
ASTRAZENECA PLC (Filed by)
CONDUIT PHARMACEUTICALS INC. (Subject)
CONDUIT PHARMACEUTICALS INC. (Subject)
CONDUIT PHARMACEUTICALS INC. (Subject)
CONDUIT PHARMACEUTICALS INC. (Subject)
Conduit Pharmaceuticals (Subject)
| Form SCHEDULE 13G/A | |
04/01/2025
8:04 PM | Charles Faith L. (Reporting)
CONDUIT PHARMACEUTICALS INC. (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
Conduit Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for CDTTW and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Conduit Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. |
04/01/2025
8:07 PM | CONDUIT PHARMACEUTICALS INC. (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
Conduit Pharmaceuticals (Issuer)
Farley Chele Chiavacci (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/01/2025
8:09 PM | CONDUIT PHARMACEUTICALS INC. (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
Conduit Pharmaceuticals (Issuer)
Fry Simon Jeremy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/01/2025
8:13 PM | CONDUIT PHARMACEUTICALS INC. (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
Conduit Pharmaceuticals (Issuer)
Lewis-Hall Freda C (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/01/2025
4:23 PM | CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Conduit Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/28/2025
3:54 PM | CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Conduit Pharmaceuticals (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/10/2025
3:30 PM | CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Conduit Pharmaceuticals (Filer)
| Form 424B5 | |
03/06/2025
7:30 AM | CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Conduit Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/20/2025
3:32 PM | CONDUIT PHARMACEUTICALS INC. (Subject)
CONDUIT PHARMACEUTICALS INC. (Subject)
CONDUIT PHARMACEUTICALS INC. (Subject)
CONDUIT PHARMACEUTICALS INC. (Subject)
Conduit Pharmaceuticals (Subject)
Nirland Ltd (Filed by)
| Form SCHEDULE 13G/A | |
02/19/2025
8:00 AM | CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Conduit Pharmaceuticals (Filer)
| Form 424B5 | |
02/12/2025
11:15 PM | CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Conduit Pharmaceuticals (Filer)
| Form EFFECT | |
02/11/2025
7:00 AM | CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Conduit Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/06/2025
4:19 PM | CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Conduit Pharmaceuticals (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
02/06/2025
7:58 AM | CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Conduit Pharmaceuticals (Filer)
| Form 424B5 | |
02/05/2025
4:30 PM | CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Conduit Pharmaceuticals (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
01/23/2025
7:15 AM | CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Conduit Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/21/2025
4:00 PM | CONDUIT PHARMACEUTICALS INC. (Subject)
CONDUIT PHARMACEUTICALS INC. (Subject)
CONDUIT PHARMACEUTICALS INC. (Subject)
CONDUIT PHARMACEUTICALS INC. (Subject)
Conduit Pharmaceuticals (Subject)
Nirland Ltd (Filed by)
| Form SCHEDULE 13G | |
01/15/2025
3:30 PM | CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Conduit Pharmaceuticals (Filer)
| Form 424B5 | |
12/20/2024
4:05 PM | CONDUIT PHARMACEUTICALS INC. (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
Conduit Pharmaceuticals (Issuer)
Fry Simon Jeremy (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
12/20/2024
4:06 PM | CONDUIT PHARMACEUTICALS INC. (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
Conduit Pharmaceuticals (Issuer)
Fry Simon Jeremy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/20/2024
4:06 PM | CONDUIT PHARMACEUTICALS INC. (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
Conduit Pharmaceuticals (Issuer)
Lewis-Hall Freda C (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/20/2024
4:06 PM | Charles Faith L. (Reporting)
CONDUIT PHARMACEUTICALS INC. (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
Conduit Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/20/2024
4:06 PM | CONDUIT PHARMACEUTICALS INC. (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
Conduit Pharmaceuticals (Issuer)
Farley Chele Chiavacci (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/20/2024
4:00 PM | CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Conduit Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/17/2024
4:15 PM | CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Conduit Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/16/2024
4:01 PM | CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Conduit Pharmaceuticals (Filer)
| Form 424B3 | |
12/09/2024
7:30 AM | CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Conduit Pharmaceuticals (Filer)
| Form DEF 14A | |
12/08/2024
11:15 PM | CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Conduit Pharmaceuticals (Filer)
| Form EFFECT | |
12/09/2024
5:11 AM | CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Conduit Pharmaceuticals (Filer)
| Form 424B3 | |
11/26/2024
4:21 PM | CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Conduit Pharmaceuticals (Filer)
| Form PRE 14A | |
11/25/2024
4:10 PM | CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Conduit Pharmaceuticals (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
Trump wipes out trillions overnight… (Ad) Is there anybody more powerful than Donald Trump right now?
In a single tariff announcement, he wiped out nearly $5 trillion in wealth from the S&P 500 and $6.4 trillion from the Dow Jones…
Not to mention the countless trillions of dollars lost in every market around the world… leaving the major political powers scrambling in fear of Trump’s next move. Whether you take some of that wealth for yourself depends on if you watch this controversial exposé |
11/25/2024
3:53 PM | CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Conduit Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/14/2024
4:20 PM | CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Conduit Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/14/2024
4:22 PM | CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Conduit Pharmaceuticals (Filer)
| Form 10-Q/A | |
11/14/2024
4:24 PM | CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Conduit Pharmaceuticals (Filer)
| Form 10-Q/A | |
11/14/2024
4:27 PM | CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Conduit Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/06/2024
5:01 AM | CONDUIT PHARMACEUTICALS INC. (Subject)
CONDUIT PHARMACEUTICALS INC. (Subject)
CONDUIT PHARMACEUTICALS INC. (Subject)
CONDUIT PHARMACEUTICALS INC. (Subject)
Conduit Pharmaceuticals (Subject)
St George Street Capital (Filed by)
| Form SC 13G/A | |
11/04/2024
4:20 PM | CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Conduit Pharmaceuticals (Filer)
| Form 424B3 | |
11/04/2024
4:21 PM | CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Conduit Pharmaceuticals (Filer)
| Form 424B5 | |
11/03/2024
11:15 PM | CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Conduit Pharmaceuticals (Filer)
| Form EFFECT | |
11/01/2024
4:10 PM | CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Conduit Pharmaceuticals (Filer)
| Form DEFA14A | |
11/01/2024
3:15 PM | CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Conduit Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/28/2024
4:15 PM | CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Conduit Pharmaceuticals (Filer)
| Form DEF 14A | |
10/28/2024
4:16 PM | CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Conduit Pharmaceuticals (Filer)
| Form DEFA14A | |
10/28/2024
4:17 PM | CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Conduit Pharmaceuticals (Filer)
| Form ARS | |
10/24/2024
5:12 AM | CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Conduit Pharmaceuticals (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
10/18/2024
3:15 PM | CONDUIT PHARMACEUTICALS INC. (Subject)
CONDUIT PHARMACEUTICALS INC. (Subject)
CONDUIT PHARMACEUTICALS INC. (Subject)
CONDUIT PHARMACEUTICALS INC. (Subject)
Conduit Pharmaceuticals (Subject)
Nirland Ltd (Filed by)
| Form SC 13G/A | |
10/16/2024
4:15 PM | CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Conduit Pharmaceuticals (Filer)
| Form PRE 14A | |
10/15/2024
4:00 PM | CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Conduit Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/11/2024
5:01 AM | ASTRAZENECA PLC (Filed by)
ASTRAZENECA PLC (Filed by)
CONDUIT PHARMACEUTICALS INC. (Subject)
CONDUIT PHARMACEUTICALS INC. (Subject)
CONDUIT PHARMACEUTICALS INC. (Subject)
CONDUIT PHARMACEUTICALS INC. (Subject)
Conduit Pharmaceuticals (Subject)
| Form SC 13G | |
10/07/2024
6:36 PM | CONDUIT PHARMACEUTICALS INC. (Subject)
CONDUIT PHARMACEUTICALS INC. (Subject)
CONDUIT PHARMACEUTICALS INC. (Subject)
CONDUIT PHARMACEUTICALS INC. (Subject)
Conduit Pharmaceuticals (Subject)
Nirland Ltd (Filed by)
| Form SC 13G/A | |
10/07/2024
6:38 PM | CONDUIT PHARMACEUTICALS INC. (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
Conduit Pharmaceuticals (Issuer)
Dovet Ltd (Reporting)
Nirland Ltd (Reporting)
Rowland Master Trust (Reporting)
Stockton Ltd (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/02/2024
4:02 PM | CONDUIT PHARMACEUTICALS INC. (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
Conduit Pharmaceuticals (Issuer)
Dovet Ltd (Reporting)
Nirland Ltd (Reporting)
Rowland Master Trust (Reporting)
Stockton Ltd (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/19/2024
3:59 PM | CONDUIT PHARMACEUTICALS INC. (Subject)
CONDUIT PHARMACEUTICALS INC. (Subject)
CONDUIT PHARMACEUTICALS INC. (Subject)
CONDUIT PHARMACEUTICALS INC. (Subject)
Conduit Pharmaceuticals (Subject)
Corvus Capital Ltd. (Filed by)
| Form SC 13D/A | |
09/19/2024
4:01 PM | Algo Holdings, Inc. (Reporting)
CONDUIT PHARMACEUTICALS INC. (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
Conduit Pharmaceuticals (Issuer)
Corvus Capital Ltd. (Reporting)
Regan Andrew (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/17/2024
3:41 PM | CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Conduit Pharmaceuticals (Filer)
| Form 424B3 | |
09/16/2024
11:15 PM | CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Conduit Pharmaceuticals (Filer)
| Form EFFECT | |
09/06/2024
4:00 PM | CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Conduit Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/04/2024
3:44 PM | CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Conduit Pharmaceuticals (Filer)
| Form S-1
Registration statement under Securities Act of 1933 | |
08/19/2024
4:00 PM | CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Conduit Pharmaceuticals (Filer)
| Form 424B3 | |
08/16/2024
3:59 PM | CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Conduit Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/12/2024
4:29 PM | CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Conduit Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/08/2024
7:30 AM | CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Conduit Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/11/2024
4:53 PM | Bligh James (Reporting)
CONDUIT PHARMACEUTICALS INC. (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
Conduit Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/11/2024
4:56 PM | CONDUIT PHARMACEUTICALS INC. (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
Conduit Pharmaceuticals (Issuer)
Farley Chele Chiavacci (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
